Key facts
- This page summarizes Yi Larson's Form 4 filing for LianBio (LIANY).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 03 Dec 2021, 15:05.
Yi Larson - 01 Dec 2021 Form 4 Insider Report for LianBio (LIANY)
- Signature
- By: /s/ Angela Chen, Attorney-in-Fact
- Issuer symbol
- LIANY
- Transaction date
- 01 Dec 2021
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 03 Dec 2021, 15:05:10 UTC
- Previous filing
- 01 Nov 2021
- Next filing
- 17 Jun 2022
- SEC filing
- View on sec.gov
Reporting owner
2 facts
Issuer context
1 fact
Transaction snapshot
2 facts
SEC evidence
5 facts
Key filing fact
Yi Larson filed Form 4 for LianBio (LIANY) on 03 Dec 2021.
Change
- Previous filing in this sequence was filed on 01 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
LIAN
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +5,996
- Change %
- +0.5%
- Price
- $0.000000
- Shares after
- 1,202,841
- Date
- 01 Dec 2021
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 5,996
- Exercise price
- $16.00
- Footnotes
- F1
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | 25% of the shares underlying the option shall vest and become exercisable on December 1, 2022; the remainder shall vest and become exercisable in three equal annual installments such that the option shall be fully vested on December 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date. |